Interaction studies of flavonoids with Bcl-2 protein to re-activate apoptosis in JurkatT-cells by induced TRAIL
-
Published:2022-12-28
Issue:
Volume:
Page:65-78
-
ISSN:2672-7277
-
Container-title:Asia Pacific Journal of Molecular Biology and Biotechnology
-
language:en
-
Short-container-title:APJMBB
Author:
Krishnaswamy Manjunatha Bukkambudi1, Kanagasabapathy Valarmathy1, Gomathi Ajitha1, Ramachandrappa Divakara1, Gurumurthy Pratheeksha1, Kumar Roshni Korpati Kiran1, Narayan Urvi1, Shanmugam Krithika1, Pillai Girinath G2
Affiliation:
1. Department of Biotechnology, The Oxford College of Engineering, Bangalore, India 2. Discovery Chemistry, Nyro Research India, Kochi, India
Abstract
Immune cell malignancy such as Acute T- cell Lymphoblastic Leukaemia is generally associated with high rate of relapse and often does not respond to salvage therapy. Thus, identification of novel treatment regimens or cell apoptosis pathways and therapeutic agents without major side effects is necessary. TRAIL-induced apoptotic pathway is one such pathway that is usually blocked by anti-apoptotic proteins like Bcl-2. This research estimated and compared the ability of few common flavonoids to re-activate TRAIL-induced apoptosis by blocking Bcl-2 protein. Studies were carried out to understand the interaction between binding energy of the Flavonoids with Bcl-2 protein in cancer cells. The pharmacokinetic and toxicity profiling was performed to study the potency of the flavonoids as a lead candidate. Baicalein was selected as lead molecule because of its lower binding energy and its ability to increase Mitochondrial Membrane Potential as studied from its ADME properties. For validation of apoptosis of Baicalein by TRAIL-induced owing to Bcl-2 analysis of cell cycle and Gene expression studies were carried out on Jurkat T cells.
Publisher
Malaysian Society for Molecular Biology and Biotechnology
Subject
Molecular Biology,Biotechnology
Reference52 articles.
1. Agarwal, S., & Sahi, P. K. 2020. National comprehensive cancer network guidelines for paediatric acute lymphoblastic leukemia. Indian Paediatrics 2020(57): 561-564. 2. Alexandra, P., Chatziathanasiadou, M. V., Karali, E., Kostaras, E., Mantzaris, M. D., Hatzimichael, E., Shin, J. S., Chi, S. W., Briasoulis, E., Kolettas, E., & Gerothanassis, I. P. 2014. Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity. ACS Chemical Biology 9(12): 2737–2741. 3. Andree, H. A., Reutelingsperger, C. P., Hauptmann, R., Hemker, H. C., Hermens, W. T., & Willems, G. M. 1990. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. Journal of Biological Chemistry 265(9): 4923-4928. 4. Azimian-Zavareh, V., Hossein, G., & Janzamin, E. 2012. Effect of lithium chloride and anti-neoplastic drugs on survival and cell cycle of androgen-dependent prostate cancer LNCap cells. Indian Journal of Pharmacology 44(6): 714-721. 5. Ballestrero, A., Nencioni, A., Boy, D., Rocco, I., Garuti, A., Mela, G. S., Van Parijs, L., Brossart, P., Wesselborg, S., & Patrone, F. 2004. tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing Jurkat cells. Cancer Cell Research 10: 1463-1470.
|
|